All Posts: News Release
-
Structural Inequities Amplify Homelessness Challenges for Pregnant People in Washington, DC
New research conducted with Washington, DC, residents who experienced homelessness during pregnancy sheds light on the intersection of homelessness, pregnancy and racial inequities. The findings underscore the urgent need for policy and practice changes to support vulnerable populations.
Category: News Release
-
Georgetown’s Cancer Center Awarded Top Designation by Federal Government
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University‘s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care. Georgetown Lombardi is the only such center in the Washington area.
Category: News Release
-
New Study: Analysis Supports New Recommendation to Begin Mammogram Screening at 40
Georgetown Lombardi’s Jeanne Mandelblatt, MD, MPH, and Amy Trentham-Dietz, PhD, of University of Wisconsin Carbone Cancer Center, were lead authors of a study informing the updated final recommendation of the United States Preventive Services Task Force regarding breast cancer screening, released April 30
Category: News Release
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Perinatal Transmission of HIV Can Lead to Cognitive Deficits
Perinatal transmission of HIV to newborns is associated with serious cognitive deficits as children grow older, according to a detailed analysis of 35 studies conducted by Georgetown University Medical Center neuroscientists. The finding helps pinpoint the geographic regions and factors that may be important for brain development outcomes related to perinatal HIV infection: mother-to-child HIV transmission during pregnancy, labor and delivery, or breastfeeding.
Category: News Release
-
A Third of Women Experience Migraines Associated with Menstruation, Most Commonly When Premenopausal
A third of the nearly 20 million women who participated in a national health survey reported migraines during menstruation, and of them, 11.8 million, or 52.5%, were premenopausal. The analysis was conducted by researchers at Georgetown University Medical Center and Pfizer, Inc., which makes a migraine medication.
Category: News Release
-
Antibiotics Aren’t Effective for Most Lower Tract Respiratory Infections
Use of antibiotics provided no measurable impact on the severity or duration of coughs, even if a bacterial infection was present, finds a large prospective study of people who sought treatment in U.S. primary or urgent care settings for lower-respiratory tract infections.
Category: News Release
-
New Book Helps Citizen Scientists Navigate Complexities of Infectious Disease Outbreaks
The COVID-19 pandemic gave rise to an explosion of novice infectious disease detectives adding to the collection of science-enthusiasts. To give these new disease detectives more tools for their craft, a new book written by two Georgetown University global health researchers, “Outbreak Atlas,” helps translate the complex interconnectedness of outbreak responses used by professionals across different fields.
Category: News Release
-
Abnormal Brain Structure Identified in Children with Developmental Language Problems
A rigorous analysis of numerous studies concludes that a part of the brain traditionally associated with movement is abnormal in children with developmental language impairments, according to Georgetown University Medical Center neuroscientists.
Category: News Release
-
Georgetown Study Explores THC/CBD Combination to Reduce Dementia-related Agitation at the End of Life
In a first-of-its-kind clinical trial, the Georgetown University Medical Center Memory Disorders Program will study the effects of an oral drug called T2:C100, which is comprised of two components found in marijuana — THC and CBD. The goal of the study is to investigate its potential to decrease agitation experienced by those with dementia at the end of life.
Category: News Release